See more : Reynaldo’s Mexican Food Company, LLC (RYNL) Income Statement Analysis – Financial Results
Complete financial analysis of Sedana Medical AB (publ) (SEDANA.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sedana Medical AB (publ), a leading company in the Medical – Devices industry within the Healthcare sector.
- K.B. Recycling Industries Ltd. (AKMY.V) Income Statement Analysis – Financial Results
- Dorel Industries Inc. (DIIBF) Income Statement Analysis – Financial Results
- Kite Realty Group Trust (KRG) Income Statement Analysis – Financial Results
- Connecticut Natural Gas Corporation PFD 8% (CTGSP) Income Statement Analysis – Financial Results
- Tandy Leather Factory, Inc. (TLF) Income Statement Analysis – Financial Results
Sedana Medical AB (publ) (SEDANA.ST)
About Sedana Medical AB (publ)
Sedana Medical AB (publ), a medical technology company, develops, markets, and sells medical devices in Sweden and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-, which are disposable medical devices that enables the administration of volatile anesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; FlurAbsorb and FlurAbsorb-S, which are active carbon filters to capture waste anaesthetic gases from the exhaust of the ventilator; FlurAbsorb accessory kit comprising accessories to connect the exhaust of the ventilator and the gas monitor to the FlurAbsorb/FlurAbsorb-S; and FlurAbsorb mount to hold the filter during scavenging of anesthetic gas. It also provides AMG-06 Gas Monitor for continuous non-invasive sidestream monitoring of CO2 and anaesthetics concentration in inspired and expired gases; Sedaconda Filling Adapter, a single-use device for safe and easy extraction of isoflurane from a Sedaconda bottle to a Sedaconda Syringe; and various accessories comprising DRYLINE II Water Traps, WaterLock 2 water trap, Nafion Dryer Tubing, and Respiratory Gas Monitoring Line. Sedana Medical AB (publ) was founded in 1999 and is headquartered in Danderyd, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 153.87M | 122.87M | 159.15M | 141.77M | 71.65M | 57.90M | 40.43M | 32.16M | 28.11M |
| Cost of Revenue | 44.89M | 36.79M | 52.45M | 52.87M | 19.23M | 15.00M | 9.48M | 9.23M | 10.26M |
| Gross Profit | 108.98M | 86.07M | 106.71M | 88.90M | 52.41M | 42.90M | 30.95M | 22.93M | 17.85M |
| Gross Profit Ratio | 70.83% | 70.06% | 67.05% | 62.71% | 73.16% | 74.09% | 76.56% | 71.30% | 63.49% |
| Research & Development | 20.81M | 19.94M | 19.70M | 7.86M | 7.35M | 362.00K | 281.60K | 0.00 | 0.00 |
| General & Administrative | 47.50M | 57.47M | 51.74M | 37.30M | 27.12M | 21.65M | 16.83M | 10.61M | 10.43M |
| Selling & Marketing | 107.24M | 112.47M | 96.57M | 65.12M | 37.33M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 154.74M | 169.94M | 148.31M | 102.42M | 27.12M | 21.65M | 16.83M | 10.61M | 10.43M |
| Other Expenses | -1.02M | 122.00K | -110.00K | 166.00K | 42.02M | 29.79M | 17.75M | 11.70M | 8.81M |
| Operating Expenses | 174.53M | 190.01M | 167.90M | 110.44M | 69.14M | 51.44M | 34.57M | 22.31M | 19.24M |
| Cost & Expenses | 219.41M | 226.80M | 220.35M | 163.31M | 88.37M | 66.44M | 44.05M | 31.54M | 29.50M |
| Interest Income | 15.17M | 3.58M | 243.00K | 189.00K | 200.00 | 2.70K | 0.00 | 2.04M | 1.34M |
| Interest Expense | 215.00K | 255.00K | 243.00K | 189.00K | 7.00K | 4.10K | 1.84M | 2.02M | 1.14M |
| Depreciation & Amortization | 7.13M | 7.81M | 8.03M | 6.70M | 3.82M | 3.64M | 2.75M | 376.60K | 212.00K |
| EBITDA | -51.67M | -64.87M | -49.10M | -17.22M | -13.07M | -2.87M | -12.50K | 1.60M | 163.00K |
| EBITDA Ratio | -33.58% | -39.70% | -27.52% | -6.66% | -15.88% | -1.48% | -0.03% | 9.44% | 0.58% |
| Operating Income | -65.55M | -103.93M | -61.20M | -21.54M | -16.73M | -8.24M | -3.49M | 618.00K | -1.39M |
| Operating Income Ratio | -42.60% | -84.59% | -38.45% | -15.19% | -23.35% | -14.23% | -8.63% | 1.92% | -4.93% |
| Total Other Income/Expenses | 6.53M | 32.95M | 4.12M | -2.75M | -244.40K | 1.72M | -1.11M | 18.90K | 194.00K |
| Income Before Tax | -59.02M | -72.93M | -57.37M | -24.10M | -16.94M | -6.52M | -4.60M | 637.00K | -1.19M |
| Income Before Tax Ratio | -38.36% | -59.36% | -36.05% | -17.00% | -23.65% | -11.26% | -11.38% | 1.98% | -4.24% |
| Income Tax Expense | 593.00K | 574.00K | 595.00K | 3.04M | -585.70K | 349.40K | -725.50K | -649.00K | 12.00K |
| Net Income | -59.61M | -73.51M | -57.97M | -27.14M | -16.36M | -6.87M | -3.88M | 1.29M | -1.21M |
| Net Income Ratio | -38.74% | -59.83% | -36.42% | -19.14% | -22.83% | -11.86% | -9.59% | 4.00% | -4.29% |
| EPS | -0.60 | -0.74 | -0.62 | -0.30 | -0.20 | -0.09 | -0.06 | 0.02 | -0.02 |
| EPS Diluted | -0.60 | -0.74 | -0.62 | -0.30 | -0.20 | -0.09 | -0.06 | 0.02 | -0.02 |
| Weighted Avg Shares Out | 99.34M | 99.34M | 92.77M | 91.57M | 83.79M | 76.63M | 68.29M | 68.29M | 68.29M |
| Weighted Avg Shares Out (Dil) | 99.34M | 99.34M | 92.77M | 91.57M | 83.79M | 76.63M | 68.29M | 68.29M | 68.29M |
Source: https://incomestatements.info
Category: Stock Reports